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INTRODUCTION 
Streptococcus pneumoniae is one of the most important 
human pathogens. It is the most common cause of otitis 
media, sinusitis and bacterial pneumonia and one of the 
most important causes of bacterial meningitis. It has 
been estimated that the pneumococcus accounts for 
3000 cases of meningitis, 500 000 cases of pneumonia 
and 7 000 000 cases of otitis media each year in the USA 
111. Since pneumonia is one of the leading causes of 
morbidity and mortality and otitis media the most 
common indication for antimicrobial prescriptions in 
developed countries, the rapidly rising prevalence of 
penicillin-resistant and multiresistant pneumococci is a 
serious public-health concern. Resistant pneumococci 
have acquired a global distribution, but the great 
difference in their prevalence between different areas 
and different countries is striking [2]. With the magn- 
tude of international travel, resistant pneumococcal 
clones have had ample opportunities to spread all over 
the world. Local conditions must therefore be important 
in determining the prevalence of resistance. Antimicro- 
bial use has been considered one of the most important 
factors in increasing the prevalence of resistance [3], but 
other factors are also likely to be important. 
Penicillin-non-susceptible pneumococci were first 
detected in Iceland in December 1988 [4], and spread 
rapidly to reach an incidence of 20% in 1993 [5]. This 
rapid rise was unexpected, since antimicrobial use is 
relatively restricted in Iceland, and antimicrobials can 
only be obtained by prescription. In addition, this 
happened at a time when the prevalence of penicillin- 
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non-susceptible pneumococci remained low in northern 
Europe. Since Iceland is an island with a population of 
only about 270 000 and excellent healthcare facilities, 
this was an ideal opportunity to study the epidemiology 
of resistant pneumococci. 
ANTIMICROBIAL RESISTANCE IN ICELAND 
Bacterial pathogens, other than the pneumococcus, have 
generally maintained good susceptibility to most anti- 
biotics in Iceland. Neither methicillin-resistant Staphylo- 
coccus atweus nor vancomycin-resistant enterococci have 
become endemic. Multiresistant and quinolone-resistant 
Enterobacteriaceae are rare, as are infections caused by 
multiresistant Psetrdomonas spp. Erythromycin-resistant 
Streptococcus pyogenes first appeared in 1998, and p-lacta- 
mase production in Haemophilus inzuenzae remains 
below 10%. This is in striking contrast to the rapid 
increase of penicillin-non-susceptible pneumococci. 
Penicillin-non-susceptible pneumococci increased 
rapidly to reach an incidence of about 20% in only 5 
years (Figure 1). This increase was almost exclusively 
due to pneumococci of serogroups 6 and 19, which, 
together with isolates of serogroup 23, constituted 
more than 98% of all penicillin-non-susceptible isolates 
(Figure 2) [5]. The majority of the serogroup 6 isolates 
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Figure 1 Yearly incidence rates for penicillin-non- 
susceptible pneumococci isolated from patient specimens. 
Repeat isolates have been excluded. 
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were multiresistant strains of serotype 6B, resistant 
to erythromycin, clindamycin, tetracycline, chloram- 
phenicol and trimethoprim-sulfamethoxazole, and had 
a penicillin MIC of 1 mg/L. This suggested that the 
serotype 6B isolates belonged to a single clone. Fifty- 
seven of these isolates were analyzed further for 
penicillin-binding protein pattern, multilocus enzyme 
genotype, and fragmentation pattern obtained by 
pulsed-field electrophoretic separation of restriction 
enzyme digests of chromosomal DNA. All isolates had 
similar or identical patterns in each molecular test, 
and were indistinguishable from a subgroup of multi- 
resistant serotype 6B pneumococci that had been 
present with high incidence in Spain. It was therefore 
considered likely that this multiresistant clone had been 
imported from Spain (the Spanish-Icelandic clone) [6]. 
RISK FACTORS FOR CARRIAGE OF RESISTANT 
PNEUMOCOCCI 
Before resistant pneumococci appeared in Iceland, 
there had been a marked increase in the prevalence of 
resistant pneumococci in South Africa [7], Spain [8] 
and Hungary [9]. Early experience &om these countries 
and in vitro models suggested that the prevalence 
would continue to rise until it reached a maximum of 
close to 50% [10,11]. In some parts of the world, 
extremely high prevalences of resistant pneumococci 
have since been described [12]. The possibility of such 
an increase was considered unacceptable in Iceland. In 
order to stop this development, risk factors had to be 
reduced. However, the risk factors were incompletely 
understood, and a study to find the main risk factors 
for carriage of resistant pneumococci was needed. 
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Figure 2 Quarterly incidence of penicillin-non-susceptible 
pneumococci of serogroups 6 ,  19 and 23. The values for 
serogroup 19 strains also include strains with penicdin MIC 
of 0.06 mg/L. 
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Figure 3 Proportion of children carrying pneumococci 
according to age. The open columns represent pneumo- 
coccal carriage, and the shaded columns carriage of 
penicdin-non-susceptible strains. 
The main reservoir of antibiotic-resistant pneumo- 
cocci is the nasopharynx of children, and carriage 
usually precedes infection [13]. Risk factors for carriage 
of resistant strains are therefore likely to be similar to 
risk factors for infections by resistant strains. A study of 
risk factors for carriage of resistant pneumococci was 
initiated in Iceland, where five health districts with 
different rates of antimicrobial prescriptions were 
selected as study geographic areas. Antimicrobial use 
ranged from 1.1 to 2.6 courses/child per year. The 
study population of 919 children under the age of 
7 years represented 15-38% of the children of that 
age living in these districts. The overall carriage of 
pneumococci was 53%, and was highest in 2-year-old 
children, i.e. the age when Icelandic children start 
attending day-care centers. Penicillin-non-susceptible 
pneumococci were carried by 5%, and the rate was 
highest (11%) in 1-year-old children (Figure 3) [14]. 
The main risk factors identified by multivariate analysis 
were young age ( < 2  years), area (highest antimicrobial 
use) and use of antimicrobials. By univariate analysis, 
recent antimicrobial use and use of trimethoprim- 
sulfamethoxazole were also significantly associated with 
carriage of resistant pneumococci [14]. Attendance at 
day-care centers did not emerge as a significant risk 
factor, since the great majority of the children were 
attending day-care centers, and only a few did not. At 
that time, studies from other countries had also 
identified antimicrobial use and young age as risk 
factors. In addition, day-care center attendance, prior 
hospitalization, living in a high-prevalence area and 
HIV infection had been identified as risk factors (Table 
The risk factors considered to be most important 
1) ~151. 
in Iceland were the following: 
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Table 1 Risk factors that are significantly associated with 
carriage of or infection with a penicillin-non-susceptible 
pneumococcus as opposed to a sensitive pneumococcus, 
and the number of studies demonstrating those risk factors 
~ 5 1 .  
Risk factor No. of studies 
Antimicrobial use 7 
Young age 6 
Day-care center attendance 3 
Prior hospitalization 3 
Isolation from upper respiratory tract 
Living in a high-prevalence area 
1 
1 
HIV infection 1 
Young age. The Icelandic population is younger than 
the populations in most neighboring countries. The 
proportion of the population 6 years old and younger 
in 1992 was 12%, and that under 15 years of age was 
25%. The proportion of the population under 15 in 
the European Union at that time ranged from 15.5% 
to 25.9% (mean 17.8%; data from Eurostat). 
Antimicrobial use. This had been increasing steadily 
in Iceland until 1990, when it was the highest of the 
Scandinavian countries. Antibacterial use in 1990 
was 23.2 defined daily dosages/1000 inhabitants per 
day in Iceland, 20.8 in Finland, 16.9 in Sweden, and 
14.0 in Norway [16]. Comparable data are not 
available from other countries, but the Scandinavian 
countries are considered to use significantly less 
antimicrobials than, for example, Spain and France. 
Day-care center attendance. This has been increasing 
in Iceland, and more than 70% of 3-5-year- 
old children have attended day-care centers since 
1989. 
The day-care centers create an ideal environment 
for the spread of resistant pneumococci. Day-care 
center attendance increases the risk of respiratory tract 
infections [17], which, in turn, increases the likelihood 
of spread of pneumococci and the number of anti- 
microbial prescriptions. This in turn increases the 
number of resistant pneumococci, which may result in 
otitis media that does not respond to the first course of 
oral antimicrobials, leading to further antimicrobial 
courses. Dissemination of pneumococcal resistance 
may indeed be facilitated in day-care centers [18]. 
INTERVENTIONS 
The intervention measures were neither introduced in 
an organized manner nor overseen by an official body. 
The interventions were mainly carried out by key 
opinion leaders, especially in clinical microbiology, 
infectious diseases, general practice and pediatrics. This 
was achieved by conveying the message in television, 
radio and newspaper interviews, by articles in the 
Icelandic Medical Journal, and at medical meetings and 
conferences. Almost everyone in Iceland has access to 
television and/or radio, and newspapers are bought by 
most households. It was therefore relatively easy to 
inform the public about the perils of improper anti- 
microbial usage. 
Prudent use of antimicrobial agents 
The interventions were focused on the overuse of 
antimicrobials in children. Physicians were urged at 
medical meetings and in the Icelandic Medical Journal 
not to prescribe antibiotics for viral infections and to 
give antibiotics less frequently for otitis media, sinusitis 
and bronchitis in children. New prescribing guidelines 
were prepared for general practitioners, and the issue of 
prudent antimicrobial use was discussed at numerous 
meetings and in the journal of the Icelandic Medical 
Association. 
The rapid increase in the incidence of resistant 
pneumococci and an increase in the number of hospital 
admissions of young children requiring parenteral 
antibiotics for otitis media attracted the attention of the 
public media. This was utilized as much as possible, to 
inform the public that antibiotics are not always helpful, 
and may in some instances be harmful. At that time, 
high-dose amoxycillin treatment had not been recog- 
nized as a possible alternative to parenteral treatment 
with either ceftriaxone or cefotaxime. 
Infection control 
The resistant pneumococci were mainly carried by 
young children in day-care centers. Studies on carriage 
of resistant pneumococci in day-care centers demon- 
strated a high carriage rate, so the exclusion of children 
carrying resistant strains from day care was not con- 
sidered to be possible. Infection control measures were 
mainly applied to infected patients in hospitals, especially 
in hospital wards treating patients with chronic lung 
diseases. Infected patients were moved to single rooms 
or cohort isolation rooms. 
EFFECT OF INTERVENTION 
It is the general feeling of Icelandic physicians that the 
propaganda in the public media changed the parents’ 
attitude towards antibiotics. Instead of demanding 
antibiotics when their children had upper respiratory 
tract infections, they question their doctors when they 
decide to prescribe antibiotics. A telephone survey 
involving 524 randomly selected parents of young 
children in Iceland demonstrated that 98.9% agree that 
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overuse of antibiotics can lead to reduced efficacy of 
the drugs. 
Antimicrobial use has been declining in Iceland 
since 1991 (Figure 4). The overall reduction in anti- 
microbial use is only 10% [19], whereas the reduction 
in use by children was 35% from 1992 to 1997 [20]. 
The reduction was most significant for the trimetho- 
primrulfamethoxazole combination and for macro- 
lides. A study in one rural health district suggests that 
the prescribing habits may be changing. The number 
of diagnoses of otitis media decreased at the same 
time as the diagnoses of non-specific virus infections 
increased. This was not due to changing epidemiology 
of these diseases, but rather the otitis media diagnosis 
may have been used to justify antimicrobial prescrip- 
tions and/or compensate for poor diagnostic methods. 
The incidence of penicillin-non-susceptible pneu- 
mococci reached a peak of about 20% in 1993, but has 
been declining since then [5]. In 1995, the incidence 
had declined to 15%, and a preliminary analysis of the 
incidence for 1996 and 1997 indicates a further drop 
The influence of the selective pressure imposed 
by the volume of drug use on temporal changes in 
resistance has been analyzed with population genetic 
methods and epidemiologic observations. The analyses 
indicated that the time scale for emergence of resistance 
is typically much shorter than the decay time after 
cessation or decline in the volume of drug use [all. 
Early intervention is therefore important when the aim 
is to keep resistance rates low. 
P O I .  
CONCLUSION 
The incidence of penicillin-non-susceptible pneumo- 
cocci increased from 0% in 1988 to 20% in 1993. 
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Figure 4 Antimicrobial use in defined daily dosages 
(DDD) per 1000 inhabitants per day in Iceland. 
Intervention measures aimed at reducing the overuse of 
antimicrobials, especially in children, were started in 
1991 and continued until 1997. This was followed by 
a significant reduction in antimicrobial use by children. 
The incidence of penicillin-non-susceptible pneumo- 
cocci has been declining since 1993. The only known 
risk factor that has been reduced is antimicrobial use. 
Community-based interventions can lead to changes 
in prescribing patterns. The fall in the incidence of 
resistant pneumococci following reduced antimicrobial 
use by children indicates that it may be possible to reduce 
resistance rates by changing prescribing patterns. 
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